HomeInsights52 Week High Stocks

Dr Reddys Laboratories Ltd 52 Week High

Dr Reddys Laboratories Ltd 52 Week High

stocks purchased

₹ 7.8 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

64.9 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

YEARHIGH

₹ 1420.2

Last updated on: Nov 21, 2024

Key Highlights

  • The 52 Week HIGH of Dr Reddys Laboratories Ltd is ₹ 1420 as of 21 Nov 24 .

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241194.55
19 Nov 20241213.95
18 Nov 20241193.35
14 Nov 20241226.05
13 Nov 20241245.7
12 Nov 20241263.1
11 Nov 20241288.2
08 Nov 20241281.85
07 Nov 20241287.15
06 Nov 20241303

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dr Reddys Laboratories Ltd News Hub

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 202410:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 202410:40

News

Mexican health regulator imposes penalty on Dr Reddy's

Dr Reddys Laboratories has received an order dated 12 November 2024, from COFEPRIS (Comisi...

Read more

14 Nov 202409:22

News

Dr Reddys Laboratories Ltd spurts 2.25%

Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoti...

Read more

06 Nov 202413:05

News

Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore

Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% YoY, primari...

Read more

05 Nov 202417:35

News

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...

Read more

08 Oct 202418:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Dr Reddys Laboratories Ltd

What is the significance of Dr Reddys Laboratories Ltd reaching its 52-week high?

Dr Reddys Laboratories Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Dr Reddys Laboratories Ltd 52-week high?

Investors monitor Dr Reddys Laboratories Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Dr Reddys Laboratories Ltd a good buy when it hits its 52-week high?

Whether Dr Reddys Laboratories Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Dr Reddys Laboratories Ltd fundamentals.

What should I consider before investing in Dr Reddys Laboratories Ltd at its 52-week high?

Before investing in Dr Reddys Laboratories Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Dr Reddys Laboratories Ltd stock price continue to rise after reaching its 52-week high?

Dr Reddys Laboratories Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*